<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94155">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01999855</url>
  </required_header>
  <id_info>
    <org_study_id>5517</org_study_id>
    <nct_id>NCT01999855</nct_id>
  </id_info>
  <brief_title>Frequency of Dysphonia in Asthmatic Patients</brief_title>
  <official_title>Evaluation of the Frequency of Dysphonia by Subjective and Objective Methods in Asthmatic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: ANSM</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For many years, it is known that asthmatics have  more often dysphonia. However, no study
      has so far analyzed the reality of dysphonia in asthmatic by making phoniatric tests.

      The etiology of dysphonia in asthmatic remains controversial. Indeed, for a long time,
      inhaled corticosteroids have been considered as responsible for organic abnormalities of the
      vocal cords. We hypothesized that women with asthma have  more often dysphonia, and that
      dysphonia is rather functional origin.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Evidence of dysphonia.  The patient will be considered as having a dysphonia if at least one of the tests (Voice Handicap Index, Rank Rough Breathy Asthenic Strained GRBAS, Quotien Phonatoire QP and Fundamental laryngeal F0) is abnormal</measure>
    <time_frame>Four week</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Asthmatic Patients and Control Group</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the Phonatory Maximum Time
Vocal Handicap Index
Scale GRBAS of Hirano
Videolaryngoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asthmatic patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Phonatory Maximum Time
Vocal Handicap Index
Scale GRBAS of Hirano
Videolaryngoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phoniatric tests</intervention_name>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>Asthmatic patients</arm_group_label>
    <other_name>- the Phonatory Maximum Time</other_name>
    <other_name>- Vocal Handicap Index</other_name>
    <other_name>- Scale GRBAS of Hirano</other_name>
    <other_name>- Videolaryngoscopy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women

          -  Aged between 18 to 65 years

          -  Patient who signed the informed consent.

          -  affiliated with a social security system.

        Patients with asthma (GINA criteria)

        -  persistent asthma with inhaled corticosteroids.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric De Blay, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pôle de Pathologie Thoracique- Hôpitaux Universitaires Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frédéric De Blay</last_name>
    <phone>03.69.55.06.39</phone>
    <email>frederic.deblay@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de pneumologie, d'allergologie et de pathologie de l'environnement</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric De Blay, Pr</last_name>
      <phone>03.69.55.06.39</phone>
      <email>frederic.deblay@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe SCHULTZ, Md PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cindy Barnig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisabeth PERI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 3, 2013</lastchanged_date>
  <firstreceived_date>November 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Dysphonia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
